Cargando…
Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock– a case report
BACKGROUND: Vasoplegia has been reported in patients receiving angiotensin receptor-neprilysin inhibitors (ARNI) with heart failure with reduced ejection fraction (HFrEF). We present a case of vasoplegic shock after initiation of ARNI in a hospitalized 65-year-old man recovering from cardiogenic sho...
Autores principales: | Almazroa, Loai, Mihajlovic, Vesna, Lawler, Patrick R., Luk, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793177/ https://www.ncbi.nlm.nih.gov/pubmed/33442637 http://dx.doi.org/10.1093/ehjcr/ytaa233 |
Ejemplares similares
-
Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice
por: Esser, Nathalie, et al.
Publicado: (2022) -
Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart Failure
por: Greenberg, Barry
Publicado: (2020) -
Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021) -
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
por: Rodenas‐Alesina, Eduard, et al.
Publicado: (2023) -
Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)